News Posts List
Kidney cancer deaths show overall decrease in Europe
04/09/2008
But study reveals wide variations between countries.
Scientists attack 'breakthrough' cancer drugs
04/09/2008
Drugs hailed as breakthrough treatments for cancer, Britain's biggest cause of death, may be less effective and cause more harm than suspected, they said.
Russian Roulette Pays Off for Antigenics
04/08/2008
A little biotech company, Antigenics (AGEN), announced that Russia has approved its kidney cancer drug, Oncophage. It's the first so-called therapeutic cancer vaccine to win full-out approval anywhere in the world.
New Clinical Data on AVEO Pharmaceuticals' Investigational Triple VEGFR Small Molecule Inhibitor AV-951 to be Presented at AACR Annual Meeting
04/08/2008
AV-951 is a novel, highly potent and specific inhibitor of VEGF receptors 1, 2 and 3. Angiogenesis inhibition has demonstrated benefit for patients with a wide range of cancer types, including renal cell carcinoma.
TLN-232 Phase II renal cell carcinoma trial
04/08/2008
Thallion Pharmaceuticals Inc. completed patient enrollment for the Phase II trial using the new continuous intravenous regimen of TLN-232 (formerly CAP-232) in refractory renal cell carcinoma patients.
They won't treat her in Canada--but they will in the USA
04/07/2008
Deb Maskens is at the U.S. National Institutes of Health (NIH) in Bethesda, Maryland, for a diagnosis she can't get at home.
Survey finds health care in Canada isn't a level playing field
04/04/2008
Survey confirms dire shortage of specialists is a significant and ongoing issue for patients in all provinces and territories.
Pfizer to launch free Sutent access programme in Nepal
04/03/2008
Company will implement the free patient assistance programme by partnering with two leading cancer hospitals in Nepal.
Sad state of health care in Australia
04/02/2008
Man must wait four months to get his kidney cancer removed. You ask yourself why that happens in modern Australia.
News Feed